www.koreanglaucoma.org
17
9ROXPH_1XPEHU
פֳણઅ़ीહાԕࠒࠩ੶ܾࣼ੭ૂीӘࠒ़੭
ણௗࣘीઊ އઊ ࣏ੋٻӋ ઔد ധف࣏ૂݴ ࣏ੋടࣳ
़ीऀહઊലࣛٻԞؘടਔކ़ी൲ഥ࠾ӘણԞҁ
ऀӖݬކफ़ܤ߆ടدਉӘ೩ਭӚܳഡਉܟഥ࠾
ઊߚૂѿٻӋઔ੶ಡඥҿޅടࣼ੭൛ࠉࠒ़੭
ણௗࣘी൲५ೂઌઊد1ԓܑࣳҿޅҥڙݼ
ৌ़ؘीࠒࠩڝઊૂ१ٻӋઔ੶ԓૻਁട֢ѿޔ܆ޅ
ӖҁਁࣘടؘPLFURVWHQWઊد
ࠒ़੭ؘܾఽҲڂѿӄܾܾӴऀٻৰઔدޣસࣼ
੭ݴ౿ന॓ܭӚ੶ܾࠒ़ѿ֢ѿؘࣼ੭॓ܭӚ੭ܾ
ѿઔدڂࠤପܾࠒ़ѿࣼஔઅҁଖଓ౿നޔ܆ޅ
Ӗҁ੶ܾඓݱӋӖޅ౿നࢆ֢ѿҲٻؘ೩٩ޅӖ ޅ੭ܾѿઔد2೩٩ޅӖޅ੭ܾѿஔࠒ़੭અ
20ી٩ކୱടӋઔدӋ্ܱઔކѿણ൭Әહ੶ܾ
҆घ१ౄؘৢߜௗݑઅઍࡘؘ೩٩ޅӖޅ੭
ѿ१ౄؘԞਁઅഡҫઊد3گ܅ࣳടҋ१ౄؘٙ
ઔৰ೩٩ޅӖޅ੭ѿ१ౄ़ؘीહઌࠒࠩ٩ா࡚ഡ
൭Әѿઔҫઊ܅Ӌଘઙനࡆ़ઔدޔ܆ޅӖҁ೩ ٩ޅӖޅ੭ܾਁفഡӄܾݴૂӖടؘટથહઌӖҁઊ
ޔ܆ޅӖҁӘࠒ࣏ઊਁઊҧܱઔৰࣳࠒ़੭
ਁفഡٳܲૂӖഡدۙഡ਼ࣛਁઅടң֢ઊഠહ੶
ܾࠋࣥഡࣼஔനݼؘࣛؽഡടҋӘӚܳઊઔد
ਭҎઊ੭ڝܾઌനޔ܆ޅӖҁઊפֳણਁفഡௗݑ હઌાԕਁઔৰӚ७֒Ҳٻৼد
ޔ܆ޅӖҁਁࣘടؘPLFURVWHQWਁؘѿѿઔ੶
ઊૻਁڂѿݴघґടܱӋഡد
1. CyPass Micro-Stent
&\3DVVPLFURVWHQWؘSRO\LPLGHથଖܾઊݗৰઔӋԢઊ ಡଙ1HZ+RUL]RQRI*ODXFRPD6XUJHU\
6XSUDFKRURLGDO0LFURVWHQW
ીӄઌ a☉ฎ᮹ݡ
Fig. 1.7KHPLFURVWHQWSODFHGLQWKHVXSUDFLOLDU\VSDFHRIWKHH\HWRIDFLOLWDWHXYHRVFOHUDODTXHRXVRXWIORZ$7KHSUR[LPDOHQGRIWKHVWHQWLV
YLVLEOHLQWKHDQWHULRUFKDPEHUE\JRQLRVFRSLFYLHZ%
A B
Journal of The Korean Glaucoma Society
JOURNAL OF THE KOREAN GLAUCOMA SOCIETY 18
ؘ635PPઊӋ਼ӄ510Pઊدઊણௗؘޔ܆ޅӖ ҁਁDELQWHUQRࠒࠩ੶ܾࣘഡد)LJ1*XLGHZLUHѿৢ
ҁӌࣷԓݼӋઔؘൌౖݴ۹ӋઔӋৰؖી٩અ੭ऀ
ҌӋઔৰPLFURVWHQWѿࣼஔӖҁਁࣳӖޅઅ੯ә
گ܅ࣳކടҲଔരടҲٻؘҫ٩ਭدણௗѿࣼ
ஔਁઝࣘઊٻJXLGHZLUHݴڎܾټدણௗԕ
ࡘୄਁӋݼѿઔৰࣳPLFURVWHQWѿીહ੶ܾણ୲ٻৰ
ઔ٩ܿഡد
மԕ184અࠕֳણઊઔؘґࠒҀפֳણ൝ઘਁࣳ&\3DVV
ࣘी १രഡ ઑࣛҿӘѿ ࡂӋٻৼؘٙ ѿણ ඕഡ ़ी
൲ഥ࠾Ԟસ138ઊৼӋޔ܆ޅࣛҋേઊ
ࠋࣥഡӄੌؘ৺ৼد4़ीפֳણৢ࣏ੋടࣳ
ઊ21PP+Jઊࣛ੶ܾٻৌَ൝ઘਁ़ࣳी൲6ґ ਖ਼ପઊ37҆घٻৼӋ࣏ੋടَടҋૂઅ़ѿ
50҆घടਔدെથґࠒҀפֳણ൝ઘڝਁҲࠕֳણ़ी
Ә&\3DVVPLFURVWHQWࣘीઅ࠾ഥ़ीӘࠕֳણز٪़
ीࡻӯന࡚ࣳࣴടؘ&203$66ലહߗઙઑࣛ
Ӵѿ߸ӵਁࣳଔരૻਁઔد
2. SOLX Gold Shunt
62/;*ROG6KXQWؘ24.ԙ9995થଖܾٻৰઔӋࠗ
ࡴѿ৺ؘ֫ઙഡಹൌౖઅࠒ़੭ણௗܾઊ32PPԢ ઊ52PPઊد)LJ256ஔહ੶ܾԠଓ࣏Ҁൌ৩ട ӋઔӋډԕࣳݼݴҌӋઔ੶֙ਁીಹҎҫઊઔ ৰޔ܆ޅӖҁਁࣳനؘਊഢഡدઊણௗؘӖ ޅґݴ౿നࣘടҲٻܾ߳ޣસґԞસҿޅކڛ
د੯ࡘਁࣳ2PPڎਁࣳӖޅґݴ१രടਉࣼஔ
Ӗҁף१ెد90ڂՌઅӖޅڂՌਁࣳࠒ੶ܾ
ґന֢ѿӋڎୄ੶ؘܾ23PPી٩ًଔരനࣳ७फ़ ܤҲޔ܆ޅӖҁ੶ܾࠆݼന֢ҁد࠺٩અLQMHFWRUݴ౿
നણௗઅৗୄࡘ࡚ࠒ੶ܾࣘടӋڎୄࡘ࡚ޔ܆
ޅӖҁ੶ܾௗ१ెدࠋټઑࣛҿӘؘܾ0HODQGڢઊ
38અפֳણ൝ઘਁ*ROGVKXQWݴࣘടӋԑ117ґਖ਼
ڎਁઊԑ9PP+J҆घടਔӋ21ਁࣳࠒേઊ
ࠋࣥടਔدӋࡂӋഡࠅઔد5
ޔ܆ޅӖҁਁࣘടؘࠒ़੭ણௗઅऀહઊࡻӯહ
ҫ੶ܾࠋٻৰઔކৈଓԪؘઑࣛӄസઊך
ٻৌӋ߸ӵ)RRGDQG'UXJ$GPLQLVWUDWLRQਁࣳ०ઌࠊ
߆യدۙഡߗઙઑࣛӴҿӘѿ৺੶ࠋټ
Ӵڝ٩OHYHO,,,ી٩અԕңކૂ१ടӋઔدԓݼӋ
ѿӋܱഢઽૻਁޔ܆ޅӖҁਁࠒ़੭ણௗݴࣘ
ടؘҫޔ܆ޅࣛҋേޔ܆ޅࠆݼڢઅટથહസઊ
ઔ़ઔدؘҫઊد7ޔ܆ޅӖҁઅણௗਁࣼ੭൛ࠉ
੶ܾઌഡޅઊൌऀٻৰࠒ़અඓݵޅѿ؟ऀઊઔ੶
ٳߜ५സਁࣳ*ROGVKXQWࣘ൲Ӵީ੶ܾࣼ੭േӚଓ ઊઘ܅ڝৰҁҫ٩ࡂӋٻৼد68گ܅ࣳઊܟഡܾࣝ१ ٩ڝઊפֳણௗݑടؘٙઔৰۙدݳࠒࠩૂ१ന
دؘٙઅઅѿઔؘҫ࡚ടކԓ൭Әݴಹزടؘٙ
ઔৰًؘࣳણԞҁઅӚ୵ӘӴѿചഢҫઊد
참고문헌
1. Classen L, Kivela T, Tarkkanen A. Histopathologic and Fig. 2.3RVWRSHUDWLYHFOLQLFDOLPDJHRIDSDWLHQWDIWHU*ROG0LFUR6KXQWLPSODQWDWLRQ1RWHWKHVKXQWLQWKHDQWHULRUFKDPEHU$ZLWKQRVKXQW
FRUQHDORUVKXQWLULVWRXFKLQJDVVHHQLQWKHJRQLRVFRSLFYLHZ%
A B
www.koreanglaucoma.org
19
9ROXPH_1XPEHU
immunohistochemical analysis of the fi ltration bleb after unsuccessful glaucoma seton implantation. Am J Oph- thalmol 1996;122:205-12.
2. Bill A. Conventional and uveo-scleral drainage of aque- ous humour in the cynomolgus monkey (macaca irus) at normal and high intraocular pressures. Exp Eye Res 1966;5:45-54.
3. Toris CB. Pharmacotherapies for glaucoma. Current Mo- lecular Med 2010;10:824-40.
4. Hoeh H, Ahmed, II, Grisanti S, et al. Early postoperative safety and surgical outcomes after implantation of a suprachoroidal micro-stent for the treatment of open- angle glaucoma concomitant with cataract surgery. J Cataract Refrac Surg 2013;39:431-7.
5. Melamed S, Ben Simon GJ, Goldenfeld M, Simon G. Ef- ficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: A pilot study. Arch Ophthalmol 2009;127:264-9.
6. Minckler DS, Hill RA. Use of novel devices for control of intraocular pressure. Exp Eye Res 2009;88:792-8.
7. Ozdamar A, Aras C, Karacorlu M. Suprachoroidal seton implantation in refractory glaucoma: A novel surgical technique. J Glaucoma 2003;12:354-9.
8. Oatts JT, Zhang Z, Tseng H, et al. In vitro and in vivo comparison of two suprachoroidal shunts. Invest Oph- thalmol Vis Sci 2013;54:5416-23.